Intraarticular Collagen in Patients With Gonarthrosis

Status Completed

Clinical Trial Summary

The objective of this clinical trial is to verify the effectiveness of polyvinyl pyrrolidone collagen in all patients with symptomatic gonarthrosis grades II-IV in patients over 40 years of age. The main objectives that this study aims to answer are the following: 1. - Document the effectiveness of intra-articular polyvinylpyrrolidone collagen in the treatment of symptomatic gonarthrosis. 2. - Compare the intensity of pain, the degree of stiffness and functionality of the joint, prior to application and one month after the therapeutic intervention. 3. - Identify demographic, clinical and therapeutic factors that influence the effectiveness of intra-articular PVP collagen in the treatment of symptomatic gonarthrosis. Patients diagnosed with symptomatic gonarthrosis Grade II-IV, referred to the Physical Medicine and Rehabilitation service within 3 months, will be selected. Two study groups will be assigned: GROUP those who received intra-articular infiltration of PVP Collagen, GROUP B: patients who received conservative treatment. Through rehabilitation with a home program for one month, in both cases, ENA and the WOMAC scale will be evaluated at the beginning of the study and after 4 weeks.

Clinical Trial Description

INTRODUCTION: Osteoarthritis is a disorder characterized by progressive deterioration of cartilage in synovial joints, affecting more than 55% of the elderly population, causing significant physical disability, implying a great challenge in medical treatment. MATERIAL AND METHODS: A sequential, simple randomized clinical trial was carried out in patients diagnosed with symptomatic gonarthrosis Grade II-IV, referred to the Physical Medicine and Rehabilitation service in 3 months, through two study groups: GROUP Those who received intra-articular infiltration of Collagen PVP, GROUP B: patients who received conservative treatment through rehabilitation with a home program for one month. In both cases, ENA and the WOMAC scale were evaluated at the beginning of the study and at 4 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06275880
Study type	Interventional
Source	Instituto Mexicano del Seguro Social
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2023
Completion date	January 10, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05233930` - Total Knee Arthroplasty and Augmented Reality-based Navigation System	N/A
Not yet recruiting	`NCT04460989` - Assessment of Patient Satisfaction After Arthroplasty: A Comparative Study by Implant Type
Recruiting	`NCT02411097` - Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism	N/A
Not yet recruiting	`NCT05435690` - Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty	N/A
Completed	`NCT06308887` - Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis	Phase 4
Recruiting	`NCT03951545` - Clinical and Radiological Impact of Tibial Cutting Int Total Knee Arthroplasty, Accelerated Navigation Versus Extramedullary Targeting	N/A
Recruiting	`NCT06302075` - Functional Recovery After Medial Monocompartmental Knee Prosthesis: One Day Protocol Versus Fast Protocol	N/A
Not yet recruiting	`NCT05877027` - Exercise vs. Topical Diclofenac vs. PRP	N/A
Recruiting	`NCT04424628` - Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis	N/A
Completed	`NCT04577521` - The Safety and Efficacy of Single IA-HA Injection in Patients With Knee Osteoarthritis: A Prospective Study
Recruiting	`NCT05814471` - Validation orthèse Pour Gonarthrose	N/A
Completed	`NCT01773226` - Evaluation of Intra-articular Injection of Autologous Protein Solution ("APS(TM)") for the Treatment of Osteoarthritis (OA)	N/A
Completed	`NCT02638831` - Ketorol Gel in Gonarthrosis and Low Back Pain	Phase 4
Completed	`NCT02977936` - Management of Joint Pain Associated With Osteoarthritis of the Knee With Association of Plant Extracts.
Recruiting	`NCT05062109` - Multimodal Geriatric Pre-authorization Before Scheduled Orthopedic Surgery	N/A
Not yet recruiting	`NCT06314191` - Adipose Tissue and Symptomatic Gonarthrosis	N/A
Recruiting	`NCT02251535` - In-vivo Comparison of Different Levels of Femoral Rollback in a Primary Total Knee Arthroplasty	N/A
Active, not recruiting	`NCT03734315` - Routine Application of Ostenil® in Patients With Gonarthrosis
Completed	`NCT03389607` - The Role of SCUBE-1 in Ischemia-reperfusion Injury
Completed	`NCT04225182` - Evaluation of the Effectiveness of a Muscular Strengthening Protocol With an Instrumented Orthosis for Gonarthrosis Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.